| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2008 | CN101163696A Histone deacetylase inhibitors |
| 04/16/2008 | CN101163695A Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| 04/16/2008 | CN101163694A Imidaz0l0-5-yl-2-anil0-pyrimidines as agents for the inhibition of cell proliferation |
| 04/16/2008 | CN101163693A Antibacterial piperidine derivatives |
| 04/16/2008 | CN101163692A Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 04/16/2008 | CN101163691A 1,3-diaryl substituted ureas as modulators of kinase activity |
| 04/16/2008 | CN101163690A 苯并噻吩异羟肟酸衍生物 Benzothiophene hydroxamic acid derivatives |
| 04/16/2008 | CN101163689A Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| 04/16/2008 | CN101163688A A process for the purification of 10-deacetylbaccatine iii from 10-de acet yl-2- debenzoyl-2-pentenoylbaccatine iii |
| 04/16/2008 | CN101163685A Pharmaceutically active diazepanes |
| 04/16/2008 | CN101163684A Quinazoline derivative having tyrosine kinase inhibitory activity |
| 04/16/2008 | CN101163683A 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 04/16/2008 | CN101163681A Phthalazinone derivative and pharmaceutical comprising the same |
| 04/16/2008 | CN101163678A 吡啶基甲基砜衍生物 Pyridyl methyl sulfone derivative |
| 04/16/2008 | CN101163677A Crystalline forms of a biphenyl compound |
| 04/16/2008 | CN101163676A Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications |
| 04/16/2008 | CN101163675A Nitrogen-containing heterocyclic compound |
| 04/16/2008 | CN101163674A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/16/2008 | CN101163673A New muscarinic receptor antagonists |
| 04/16/2008 | CN101163670A Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 04/16/2008 | CN101163668A Calcium bis [ (2s) - 3- [3-[ (2s) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
| 04/16/2008 | CN101163667A Phenyl ethyne compounds |
| 04/16/2008 | CN101163493A Uronic acid and probiotics |
| 04/16/2008 | CN101163490A Artificial cerebrospinal fluid |
| 04/16/2008 | CN101163489A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension |
| 04/16/2008 | CN101163488A Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees |
| 04/16/2008 | CN101163487A Urethral condoms and liquid femidoms |
| 04/16/2008 | CN101163486A Use of azithromycin for the production of a medicament for treatment of ocular infections |
| 04/16/2008 | CN101163485A Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes |
| 04/16/2008 | CN101163484A The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis |
| 04/16/2008 | CN101163483A Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin d compounds or mimics thereof |
| 04/16/2008 | CN101163482A N-alkyl-azacycloalkyl nmda/nr2b antagonists |
| 04/16/2008 | CN101163481A Improved gacyclidine formulations |
| 04/16/2008 | CN101163480A Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 04/16/2008 | CN101163479A Solid pharmaceutical dosage formulation |
| 04/16/2008 | CN101163478A Compounds for inflammation and immune-related uses |
| 04/16/2008 | CN101163477A Multimediator dopamine transport inhibitors, and uses related thereto |
| 04/16/2008 | CN101163476A Roflumilast for the treatment of pulmonary hypertension |
| 04/16/2008 | CN101163475A 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
| 04/16/2008 | CN101163474A Drug for curing corneal and conjunctival disease |
| 04/16/2008 | CN101163473A Anticancer combination therapy using sunitinib malate |
| 04/16/2008 | CN101163472A Vla-4 antagonists |
| 04/16/2008 | CN101163471A Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions |
| 04/16/2008 | CN101163470A Association between ferroquine and an artemisinine derivative for treating malaria |
| 04/16/2008 | CN101163469A 腹膜透析液 Peritoneal dialysate |
| 04/16/2008 | CN101163468A Novel combinational use of sulfonamide compound |
| 04/16/2008 | CN101163467A Dosing regimes for trans-clomiphene |
| 04/16/2008 | CN101163466A Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-l,3- cyclohexanedione in the treatment of parkinson's disease |
| 04/16/2008 | CN101163465A Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors |
| 04/16/2008 | CN101163455A Non-irritating compositions containing zinc salts |
| 04/16/2008 | CN101163415A Nutritional supplement for HIV patients |
| 04/16/2008 | CN101163414A Food or drug comprising lactic acid bacterium containing mineral |
| 04/16/2008 | CN101161688A Novel process for synthesizing povidone iodine by gas phase/ solid phase reaction |
| 04/16/2008 | CN101161676A Saltant APOBEC3G molecule inhibiting HIV reproduction and uses thereof |
| 04/16/2008 | CN101161670A Ursolic acid chemical modified compound amine having antitumor activity |
| 04/16/2008 | CN101161668A Application of flavone c-glycosides in preparation of drugs curing and preventing hepatitis |
| 04/16/2008 | CN101161654A Antineoplastic active canthardin derivative and method for preparing same |
| 04/16/2008 | CN101161652A Quinolizine derivatives having antibacterial activity |
| 04/16/2008 | CN101161646A Ketones compound preventing cells from oxidation damage, preparation method and uses thereof |
| 04/16/2008 | CN101161645A Urea derivatives as well as preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161629A 4'-substituted benzyloxy-phenyl butadiene derivatives and preparation and uses thereof |
| 04/16/2008 | CN101161290A Beta-elemi alkene polyglycol amine derivant as well as its synthesis method and purpose |
| 04/16/2008 | CN101161288A Enganced tumour cell cracking article of oligonucleotide and method for treating knub |
| 04/16/2008 | CN101161281A A Chinese medicine liniment for treating cervical spondylosis, lumbar disease and its preparing method |
| 04/16/2008 | CN101161276A Nebula pressurized spray for treating rehabilitation of exogenous injury, empyrosis and bone fracture as well as its preparing method |
| 04/16/2008 | CN101161263A A Chinese medicine for treating leukaemia and its preparing method |
| 04/16/2008 | CN101161261A A Chinese medicine for treating osteoproliferation rheumatalgia |
| 04/16/2008 | CN101161260A A medicine for treating beriberi |
| 04/16/2008 | CN101161253A Pharmaceutical composition of melon betel or its extract and safflower or its extract |
| 04/16/2008 | CN101161246A New purpose of ginsenoside Rh* |
| 04/16/2008 | CN101161245A Purpose of toluylene glycosides and its derivant for restraining synapse ribonucleoprtein excess expression |
| 04/16/2008 | CN101161244A Nimodipine tablet and its preparing method |
| 04/16/2008 | CN101161243A An injection for treating brain apoplexy and its sequela as well as its preparing method |
| 04/16/2008 | CN101161241A Technique of preparing amlodipine besylate tablets |
| 04/16/2008 | CN101161240A Levodropropizine medicinal composition for oral cavity use |
| 04/16/2008 | CN101161239A PLGA Gemcitabine sustained-release microsphere and its preparing method |
| 04/16/2008 | CN101161237A Steady cisplatin element lipoid plastid and method for preparing the same |
| 04/16/2008 | CN101161235A Dasatini sustained-release implants for treating entity knub |
| 04/16/2008 | CN101161234A Erlotinib sustained-release implants for treating entity knub |
| 04/16/2008 | CN101161233A Ebstine solid oral preparation and its preparing method |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/16/2008 | CN100381457C 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 04/16/2008 | CN100381456C A segment differential nucleotide sequence of smallpox virus genom |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381446C Aminomethyl-substituted thiazolobenzimidazole derivative |
| 04/16/2008 | CN100381445C Preparing process of cefetamet sodium |
| 04/16/2008 | CN100381444C Silicon phthalocyanine compound and composite, their preparation and application thereof |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381435C Extractive of general flavone from blackberry lily, preparation method and application in preparing medication |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381426C Growth promotion method |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/16/2008 | CN100381423C Novel piperidine derivatives as modulators of chemokine receptor CCR5 |
| 04/16/2008 | CN100381179C Stent with functional nanometer drug-carried coat |
| 04/16/2008 | CN100381172C Treating prostate cancer with anti-ErbB2 antibodies |
| 04/16/2008 | CN100381163C Medicine comprising rilmenidine |
| 04/16/2008 | CN100381152C Medicinal granules of nourishing Yin and tonifying stomach, capsule and tablet preparing method |